A summary of goodwill by segment and related adjustments is provided below:


	Goodwill
	Hospice			Personal Care			Home Health		Total
	(Amounts In Thousands)
Goodwill at December 31, 2021	$	328,334		$	152,688		$	23,370	$	504,392
Additions for acquisitions		69,446			—			8,910		78,356
Adjustments to previously recorded goodwill		(52	)		—			141		89
Goodwill at December 31, 2022		397,728			152,688			32,421		582,837
Additions for acquisitions		35,071			601			44,274		79,946
Adjustments to previously recorded goodwill		—			(13	)		225		212
Goodwill at December 31, 2023	$	432,799		$	153,276		$	76,920	$	662,995

In 2023, the Company recognized goodwill in the hospice and home health segments of $35.0 million and $44.3 million, respectively, related to the acquisition of Tennessee Quality Care and $0.6 million related to the acquisition of CareStaff in the personal care services segment. In connection with the acquisition of JourneyCare in 2022, the Company recognized goodwill in its hospice segment of $69.4 million and $8.9 million with the acquisition of Apple Home in 2022 in our home health segment.

Goodwill adjustments to previously recorded goodwill are generally related to accounts receivable and accrued expenses based on the final valuations. See Note 3 to the Notes to Consolidated Financial Statements for additional information regarding the acquisitions made by the Company in 2022 and 2023.

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from one to twenty-five years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from five to ten years.

Goodwill and certain state licenses are not amortized pursuant to ASC Topic 350. We test intangible assets with indefinite useful lives for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. The Company estimates the fair value of the reporting unit using both a discounted cash flow model as well as a market multiple model. The cash flow forecasts are adjusted by an appropriate discount rate based on the Company’s estimate of a market participant’s weighted-average cost of capital. These models are both based on the Company’s best estimate of future revenues and operating costs and are reconciled to the Company’s consolidated market capitalization, with consideration of the amount a potential acquirer would be required to pay, in the form of a control premium. The determination of fair value in the Company’s goodwill impairment analysis is based on an estimate of fair value for each reporting unit utilizing known and estimated inputs at the evaluation date. Some of those inputs include, but are not limited to, the most recent price of the Company’s common stock and fair value of long term debt, estimates of future revenue and expense growth, estimated market multiples, expected capital expenditures, income tax rates and cost of invested capital. Significant assumptions used in the analysis included a 10.0% discount rate and long-term revenue growth rates that ranged from 3.5% to 5.8%. The Company did not record any impairment charges for the years ended December 31, 2023, 2022 or 2021.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following at December 31, 2023 and 2022:


		December 31, 2023							December 31, 2022
		(Amounts in Thousands)							(Amounts in Thousands)
	Estimated Useful Life	Gross carrying value		Accumulated amortization			Net carrying value		Gross carrying value		Accumulated amortization			Net carrying value
Customer and referral relationships	5-10 years	$	44,672	$	(39,566	)	$	5,106	$	44,672	$	(38,088	)	$	6,584
Trade names and trademarks	1-20 years		59,566		(23,857	)		35,709		52,046		(21,058	)		30,988
Non-competition agreement	3-5 years		6,785		(5,601	)		1,184		6,785		(4,785	)		2,000
State Licenses	6-10 years		12,671		(9,015	)		3,656		12,517		(7,009	)		5,508
State Licenses	Indefinite		46,328		—			46,328		27,108		—			27,108
Total intangible assets		$	170,022	$	(78,039	)	$	91,983	$	143,128	$	(70,940	)	$	72,188

During the year ended December 31, 2023, the Company acquired indefinite-lived state licenses and a trade name of $7.6 million and $2.1 million, respectively, in its hospice segment related to the acquisition of Tennessee Quality Care. The Company also acquired indefinite-lived state licenses and trade name of $11.6 million and $5.4 million, respectively, in its home health segment in connection with the Tennessee Quality Care acquisition.

During the year ended December 31, 2022, the Company acquired indefinite-lived state licenses and trade names of $4.8 million and $9.0 million, respectively, related to the acquisition of JourneyCare. During the year ended December 31, 2022, the Company acquired indefinite lived state licenses and trade names of $1.2 million and $0.1 million, respectively, related to the acquisition of Apple Home.

Amortization expense related to the identifiable intangible assets amounted to $7.1 million, $7.2 million and $8.5 million for the years ended December 31, 2023, 2022 and 2021, respectively.

The weighted average remaining useful life of identifiable intangible assets as of December 31, 2023 is 10.23 years.

The estimated future intangible amortization expense is as follows:


For the year ended December 31,	Total (Amount in Thousands)
2024	$	7,047
2025		5,424
2026		4,800
2027		4,178
2028		3,285
Thereafter		20,921
Total, intangible assets subject to amortization	$	45,655